Braveheart Bio, Inc.

Braveheart Bio, Inc.

NNASDAQ:BRVE
18.78
USD
-0.71
(-3.64%)
-1.10EPS
1.82BMarket Cap
Mar 03Next Earn

Braveheart Bio, Inc. Documents

Q1 FY2026 · Presentation

69fe4469252cbf0ec174a43f_6c6e16e4975f5cd7e2f6091e84cde254_Phase 2 study to evaluate BHB-1893 in symptomatic nHCM · 16 pages

Read Braveheart Bio, Inc.'s results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q1 FY2026 documents